Continuous Glucose Monitoring in Diabetic Long Distance Runners

Abstract

Marathon running is growing in popularity, and many diabetic patients are participating in various marathon races all over the world each year. This study aimed to investigate the prevalence and extent of glycemic excursions (hypo- and hyperglycemic) during a marathon run in patients with well-controlled diabetes mellitus using a continuous glucose monitoring system (CGMS). Five subjects with type 1 and one patient with type 2 diabetes mellitus were monitored with the Medtronic MiniMed CGMS during the 2002 Vienna City Marathon (n = 3) or the “Fernwärme run” (n = 3) long distance runs of 42.19/15.8 km. All six patients finished their course. The CGSM system was well tolerated in all patients over an average duration of 34 ± 4.0 hours and it did not limit the patients' activities. The mean running time for the Vienna city marathon was 257 ± 8 min (247 to 274 min) and for the Fernwärme run 134 ± 118 min (113 to 150 min). A total of 1470 blood glucose measurements (mean 245 readings per subject) were performed. During and after the marathons frequent hypo- and hyperglycemic episodes with and without clinical symptoms were measured. Our data confirm that the CGMS may help to identify asymptomatic hypoglycemia or hyperglycemia during and after a long distance run. The system may also be helpful to improve our understanding about the individual changes of glucose during and after a marathon and may protect hypoglycemic or hyperglycemic periods in future races.

Key words

Diabetes mellitus - hypoyglycemia - hyperglycemia - exercise

References

• 1 American Diabetes Association . Diagnosis and classification of diabetes mellitus.  Diabetes Care. 2004;  27 5-10
• 2 Amin R, Ross K, Acerini C L, Edge J A, Warner J, Dunger D B. Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system.  Diabetes Care. 2003;  26 662-667
• 3 Berger M, Assal J P, Jorgens V. Physical exercise in the diabetic. The importance of understanding endocrine and metabolic responses.  Diabetes Metab. 1980;  6 59-69
• 4 Clarke W L, Gonder-Frederick L A, Richards F E, Cryer P E. Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control.  Diabetes. 1991;  40 680-685
• 5 Draznin M B. Type 1 diabetes and sports participation: strategies for training and competing safely.  Phys Sportsmed. 2000;  28 49-56
• 6 Grimaldi A, Bosquet F, Davidoff P, Digy J P, Sachon C, Landault C, Thervet F, Zoghbi F, Legrand J C. Unawareness of hypoglycemia by insulin-dependent diabetics.  Horm Metab Res. 1990;  22 90-95
• 7 Grimm J, Muchnick S. Type 1 diabetes and marathon running.  Diabetes Care. 1993;  16 1624
• 8 Gross T M, Bode B W, Einhorn D, Kayne D M, Reed J H, White N H, Mastrototaro J J. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use.  Diabetes Technol Ther. 2000;  2 49-56
• 9 Guerci B, Floriot M, Bohme P, Durain D, Benichou M, Jellimann S, Drouin P. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs.  Diabetes Care. 2003;  26 582-589
• 10 Hay L C, Wilmshurst E G, Fulcher G. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.  Diabetes Technol Ther. 2003;  5 19-26
• 11 Kaufman F R, Austin J, Neinstein A, Jeng L, Halvorson M, Devoe D J, Pitukcheewanont P. Nocturnal hypoglycemia detected with the continuous glucose monitoring system in pediatric patients with type 1 diabetes.  J Pediatr. 2002;  141 625-630
• 12 Kaufman F R, Gibson L C, Halvorson M, Carpenter S, Fisher L K, Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects.  Diabetes Care. 2001;  24 2030-2034
• 13 McGowan K, Thomas W, Moran A. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled Type 1 Diabetes.  Diabetes Care. 2002;  25 1499-1503
• 14 Meinders A E, Willekens F L, Heere L P. Metabolic and hormonal changes in IDDM during long-distance run.  Diabetes Care. 1988;  11 1-7
• 15 Metzger M, Leibowitz G, Wainstein J, Glaser B, Raz I. Reproducibility of glucose measurements using the glucose sensor.  Diabetes Care. 2002;  25 1185-1191
• 16 Rebrin K, Steil G M, van Antwerp W P, Mastrototaro J J. Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring.  Am J Physiol. 1999;  277 561-571
• 17 Roberts S O, Robergs R A, Hanson P. Clinical Exercise Testing and Prescription: Theory and Application. Vol. 22. Boca Raton, FL; CRC Press 1997: 90-95
• 18 The Diabetes Research in Children Network (DirecNet) Study Group . The accuracy of the GlucoWatch Biographer in children with type 1 diabetes: results of the Diabetes Res in Children Network (DirecNet) accuracy study.  Diabetes Technol Ther. 2003;  5 791-800
• 19 The Diabetes Research in Children Network (DirecNet) Study Group . The accuracy of the CGMS in children with type 1 diabetes: results of the Diabetes Res in Children Network (DirecNet) accuracy study.  Diabetes Technol Ther. 2003;  5 781-789
• 20 The Diabetes Research in Children Network (DirecNet) Study Group . Accuracy of the GlucoWatch G2 Biographer and the Continuous Glucose Monitoring System During Hypoglycemia.  Diabetes Care. 2004;  27 722-726
• 21 Zavalkoff S R, Polychronakos C. Evaluation of conventional blood glucose monitoring as an indicator of integrated glucose values using a continuous subcutaneous sensor.  Diabetes Care. 2002;  25 1603-1606